§

ARAGON PHARMACEUTICALS, INC.

2020000990 (P.T.A.B. Dec. 30, 2020)
ARAGON PHARMACEUTICALS, INC.

5 Cited authorities

  1. DyStar Textilfarben GmbH & Co. Deutschland KG v. C.H. Patrick Co.

    464 F.3d 1356 (Fed. Cir. 2006)   Cited 135 times   4 Legal Analyses
    Holding based on the record that "[t]he presence of certain secondary considerations of nonobviousness are insufficient as a matter of law to overcome our conclusion that the evidence only supports a legal conclusion that claim 1 would have been obvious"

  2. In re Jung

    637 F.3d 1356 (Fed. Cir. 2011)   Cited 24 times   4 Legal Analyses
    Holding the prima facie case during patent examination “is merely a procedural device that enables an appropriate shift of the burden of production” from the PTO to the patent applicant

  3. In re Biedermann

    733 F.3d 329 (Fed. Cir. 2013)   Cited 8 times   2 Legal Analyses

    No. 2013–1080. 2013-10-18 In re Lutz BIEDERMANN and Jurgen Harms. Luke Dauchot, Kirkland & Ellis, LLP, of Los Angeles, CA, argued for appellant. With him on the brief were Nimalka R. Wickramasekera and Benjamin A. Herbert. Of counsel on the brief was Mark Garscia, Christie, Parker & Hale, LLP, of Glendale, CA. Monica B. Lateef, Associate Solicitor, United States Patent and Trademark Office, of Alexandria, VA, argued for appellee. With her on the brief were Nathan K. Kelley, Deputy Solicitor, and

  4. Section 103 - Conditions for patentability; non-obvious subject matter

    35 U.S.C. § 103   Cited 6,105 times   470 Legal Analyses
    Holding the party seeking invalidity must prove "the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains."

  5. Section 1.42 - Applicant for patent

    37 C.F.R. § 1.42   1 Legal Analyses

    (a) The word "applicant" when used in this title refers to the inventor or all of the joint inventors, or to the person applying for a patent as provided in §§ 1.43 , 1.45 , or 1.46 . (b) If a person is applying for a patent as provided in § 1.46 , the word "applicant" refers to the assignee, the person to whom the inventor is under an obligation to assign the invention, or the person who otherwise shows sufficient proprietary interest in the matter, who is applying for a patent under § 1.46 and